Streetbeat News

Products Services

DOGEUSD

SHIBUSD

Shiba Inu (CRYPTO: SHIB) surged over 15% following the announcement of a new privacy-focused network on the Shibarium blockchain in partnership with Zama. This network utilizes Fully Homomorphic Encryption and is supported by the Shiba Inu ecosystem token TREAT. The Shibarium network aims to offer low-fee financial services and gaming. Significant increases in new accounts and large transactions indicate strong buying activity. Analyst Altcoin Sherpa predicts potential huge runs for both Dogecoin (CRYPTO: DOGE) and Shiba Inu, highlighting their promising charts.

Portfolio Pulse from Khyathi Dalal

February 29, 2024 | 5:54 pm

INTC

Intel has officially announced the launch of Altera, a new standalone company focused on FPGA (Field-Programmable Gate Array) technology. Altera will operate under its own brand, marking a significant move in Intel's business strategy.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 5:51 pm

ROKU

Financial analysis reveals a bearish sentiment among traders on Roku (NASDAQ:ROKU), with 59% showing bearish tendencies in recent options activity. The analysis highlighted 27 unusual trades, with a significant portion being calls. The price window eyed by traders ranges from $20.0 to $110.0. Roku, a leading streaming platform, is currently trading up by 1.74% at $64.82, with potential oversold conditions indicated by RSI readings. The company's earnings release is anticipated in 55 days.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 5:46 pm

AAPL

GOOG

RIVN

TSLA

Apple Inc's abandoned electric vehicle (EV) project, known as Titan, considered using Siri as a steering mechanism and had explored a deal with Tesla Inc. The project, which began in 2014, faced multiple stalls and leadership changes. Apple's initial vision included a car without a steering wheel, controlled by Siri, resembling a European minivan. The development of Apple's EV followed failed acquisition talks with Tesla, where Elon Musk sought to be CEO of the combined entity, leading to the collapse of negotiations. Apple's interest in the EV market remains, with speculation about potential acquisitions like Rivian Automotive.

Portfolio Pulse from Chris Katje

February 29, 2024 | 5:43 pm

VLCN

Volcon, Inc. (NASDAQ:VLCN) shares surged 36.36% to $1.65 after announcing the delivery of its first production vehicle, the Volcon Stag, to the U.S. Army Corps of Engineers for evaluation. This marks a significant rebound following a 100% dip over the last year. The company's CEO, John Kim, highlighted the successful launch of the Stag, the fastest-production electric UTV, and the ongoing full production of Grunt EVO motorcycles. Volcon aims to ramp up Stag production and sales while continuing its electric motorcycle deliveries globally.

Portfolio Pulse from Nabaparna Bhattacharya

February 29, 2024 | 5:37 pm

LUNR

SIDU

Sidus Space, Inc. (NASDAQ:SIDU) shares surged after announcing its LizzieSat satellite is ready for launch with SpaceX, aiming for a March 2024 launch. The satellite will support various industries with its data collection capabilities and onboard AI. The stock's movement is compared to Intuitive Machines, Inc. (NASDAQ:LUNR), which also saw a significant price increase following a successful launch.

Portfolio Pulse from Erica Kollmann

February 29, 2024 | 5:23 pm

BYND

Financial analysis reveals a bullish trend in Beyond Meat's (NASDAQ:BYND) options activity, with 60% of traders showing bullish sentiment. The analysis highlighted 10 unusual trades, with a focus on a price band between $7.0 and $40.0. Beyond Meat, known for its plant-based meats, has seen its stock price decrease by -3.36%, currently trading at $9.5. The company's international revenue accounted for 31% of 2021 sales, with expectations of food-service sales recovering to 50% due to new deals with McDonald's and Yum Brands.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 5:01 pm

MRNA

Significant investors have taken a predominantly bearish stance on Moderna (NASDAQ:MRNA), with options data revealing 75% bearish sentiment. The targeted price range for MRNA is between $60.0 and $100.0. Despite this, the current price of MRNA is $93.85, down 3.73%, with neutral RSI indicators. Analysts have mixed opinions, with a consensus target price of approximately $100.67, varying ratings from 'Outperform' to 'Reduce'. Moderna's mRNA technology has seen rapid validation, especially with its COVID-19 vaccine, and it continues to explore various therapeutic areas.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 5:01 pm

IOVA

Iovance Biotherapeutics (NASDAQ:IOVA) has seen a surge in options activity, with a notable split between bullish and bearish sentiments among high-rolling investors. The options trades, predominantly calls, target a price range of $7.5 to $30.0. Despite a current price drop of -3.61% to $16.8, professional analysts maintain positive ratings, with a consensus target price of $24.4. The company, a pioneer in T-cell therapy for solid tumor cancers, is preparing for potential U.S. regulatory approval and commercialization.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 5:01 pm

DNLI

Goldman Sachs has reaffirmed its Buy rating on Denali Therapeutics (NASDAQ:DNLI) but reduced its price target from $73.00 to $50.00. Despite this adjustment, DNLI's shares have risen by 2.62% in the last 24 hours to $20.74. A move to the new target price would represent a 141.08% increase from the current level. Denali Therapeutics is focused on developing treatments for neurodegenerative diseases, with several key products in its pipeline.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 5:00 pm